1
Precise Gene Signature for Predicting Outcomes in PDAC
Condition(s):Stage I-II Pancreatic Ductal Adenocarcinoma (PDAC); Precise Prognostic and Predictive SignatureLast Updated:July 7, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Stage I-II Pancreatic Ductal Adenocarcinoma (PDAC); Precise Prognostic and Predictive SignatureLast Updated:July 7, 2022Completed
Condition(s):Colorectal CancerLast Updated:November 18, 2015Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.